Bellwether Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-398
Closed -$22K 141
2017
Q1
$22K Sell
398
-7,498
-95% -$411K 0.06% 278
2016
Q4
$461K Buy
+7,896
New +$432K 0.41% 67
2016
Q2
$552K Buy
+7,508
New +$531K 0.61% 36

Other funds holding BMY

Bellwether Investment Group's BMY Position: Q2 2017 in Review

Bellwether Investment Group sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 398 shares — an estimated $22K sold.

Bellwether Investment Group first reported a position in BMY in Q2 2016 and held it in 3 quarters. The position peaked at $552K in Q2 2016. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Bellwether Investment Group reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 398 Bristol-Myers Squibb shares in Q2 2017, an estimated $22K.
  • Bellwether Investment Group first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 3 quarters.
  • Bellwether Investment Group's Bristol-Myers Squibb position peaked at $552K in Q2 2016.
  • 1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Bellwether Investment Group's 13F filing for Q2 2017, filed 8 Aug 2017.